Safety of St John's wort (Hypericum perforatum)

被引：151

作者：

Yue, QY ^{[1
]}

Bergquist, C ^{[1
]}

Gerdén, B ^{[1
]}

机构：

[1] Med Prod Agcy, S-75103 Uppsala, Sweden

来源：

LANCET | 2000年 / 355卷 / 9203期

关键词：

D O I：

10.1016/S0140-6736(05)73227-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：576 / 577

页数：2

共 5 条

[1] Second thoughts about safety of St John's wort [J].

Ernst, E .

LANCET, 1999, 354 (9195) :2014-2016

[2] Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) [J].

Johne, A ;

Brockmöller, J ;

Bauer, S ;

Maurer, A ;

Langheinrich, M ;

Roots, I .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (04) :338-345

[3] Human P450 metabolism of warfarin [J].

Kaminsky, LS ;

Zhang, ZY .

PHARMACOLOGY & THERAPEUTICS, 1997, 73 (01) :67-74

[4]

Kerb R., 1997, European Journal of Clinical Pharmacology, V52, pA186

[5] Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone [J].

LeBel, M ;

Masson, E ;

Guilbert, E ;

Colborn, D ;

Paquet, F ;

Allard, S ;

Vallée, F ;

Narang, PK .

JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (11) :1042-1050

← 1 →